Adoptive cell therapy using tumor‐infiltrating lymphocytes for melanoma refractory to immune‐checkpoint inhibitors-Reference-Cited by-同舟云学术

Adoptive cell therapy using tumor‐infiltrating lymphocytes for melanoma refractory to immune‐checkpoint inhibitors

Published:2021-06-30 Issue:8 Volume:112 Page:3163-3172
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Hirai Ikuko¹^ORCID,Funakoshi Takeru¹,Kamijuku Hajime²,Fukuda Keitaro¹,Mori Mariko¹,Sakurai Masatoshi³,Koda Yuya³,Kato Jun³,Mori Takehiko³,Watanabe Naohide⁴,Noji Shinobu²,Yaguchi Tomonori²,Iwata Takashi²⁵,Ohta Shigeki²,Fujita Tomonobu²,Tanosaki Ryuji⁴,Handa Makoto⁴,Okamoto Shinichiro²,Amagai Masayuki¹,Kawakami Yutaka²⁶

Affiliation:

1. Department of Dermatology Keio University School of Medicine Tokyo Japan

2. Institute for Advanced Medical Research Division of Cellular Signaling Keio University School of Medicine Tokyo Japan

3. Division of Hematology Department of Medicine Keio University School of Medicine Tokyo Japan

4. Center for Transfusion Medicine and Cell Therapy Keio University School of Medicine Tokyo Japan

5. Department of Obstetrics and Gynecology Keio University School of Medicine Tokyo Japan

6. Department of Immunology School of Medicine International University of Health and Welfare Chiba Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15009

Reference26 articles.

1. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

2. A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes

3. Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma.

4. Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option

5. Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and perspectives of clinical trials for tumor-infiltrating lymphocyte therapy;Clinical and Translational Oncology;2024-07-30

2. Recent advances in immunotherapy and its combination therapies for advanced melanoma: a review;Frontiers in Oncology;2024-07-16

3. Current knowledge about immunotherapy resistance for melanoma and potential predictive and prognostic biomarkers;Cancer Drug Resistance;2024-05-13

4. Multidisciplinary approach and treatment of acral and mucosal melanoma;Frontiers in Oncology;2024-02-26

5. A Review of Current and Pipeline Drugs for Treatment of Melanoma;Pharmaceuticals;2024-02-07